Considering that HER3 expression level varies among acral melanoma patients [48] and some patients were negative for HER3, it seemed that our newly established cell line originated from a HER3-negative fraction of the tumor cells. This evidence concerns the gene ERBB3 and acral lentiginous melanoma.